We discussed a few things including:
1. Their career journeys
2. How Jim landed in an investing career
3. Nina's unique path to entrepreneurship
4. State of investing landscape/outlook
5. Trends, opportunities in biotech and ecosystem
Jim Gunton has invested in privately-held growth technology companies for more than 20 years. Before co-founding in 2001 the $80 million NJTC Venture Fund, Jim was a partner at Edison Venture Fund and a manager at Oracle Corporation in the Silicon Valley. He served formerly as a Governor of the National Association of Small Business Investment Companies (NASBIC).
Jim earned a BS from Stanford University and an MBA with distinction from Duke University. He has served on the board of numerous private and public companies including Achieve3000, Amber Road (NYSE: AMBR), CytoSorbents (NASDAQ: CTSO), InstaMed, IntegriChain and CareGain.
-----
Nina Tandon is the co-founder and CEO of EpiBone, a biotech company that grows bone and cartilage for skeletal reconstruction. With decades of experience as a scientist and entrepreneur, Nina is known for her TED Talks, has published in Forbes magazine, and was featured on the Netflix series “Human: The World Within.”
Recognized for her accomplishments as a female scientist and entrepreneur, Nina was named one of the 100 Most Creative People in Business by Fast Company Magazine; an Ernst & Young Winning Woman; and Goldman Sachs’ 100 Most Intriguing Entrepreneurs, among other awards. Nina holds a master’s in Bioelectrical Engineering from Massachusetts Institute of Technology (MIT), and two advanced degrees from Columbia University – an MBA and a PhD in Biomedical Engineering.
#podcast #AFewThingsPodcast